Apimeds Pharmaceuticals US

APUS

Apimeds Pharmaceuticals US has been a target of short sellers for a while. The current short interest of 4.84% is roughly at the average of the last 12 months (5.56%).

Short Interest Trend

Share Price

Total NSP

4.84%

-0.43%

vs. last month

Also interesting? All insider buys at Apimeds Pharmaceuticals US

Note: The short selling data for Apimeds Pharmaceuticals US may be distorted by a recent stock split!

Found an error? Questions? Ideas?